Biotech

All Articles

Novartis ignites brand-new phase of Voyager pact along with $15M capsid bargain

.Novartis is opening a new outpost in its partnership with Voyager Therapeutics, paying $15 thousand...

Lilly blog posts a lot more positive data on its regular insulin prospect

.On the heels of an FDA denial for its own primary rival Novo Nordisk, Eli Lilly is actually pushing...

IN 8bio halts period 2 test, gives up half of workforce

.Merely a couple of months after dosing the 1st individual in a phase 2 trial for newly detected gli...

Lilly, Haya ink $1B biobuck weight problems contract to browse dark genome

.Eli Lilly's search for weight problems intendeds has actually led it to the black genome. The Big P...

ArsenalBio elevates $325M, rotates away from previous lead possession

.Collection Biosciences is carrying on up. The tissue therapy provider has added $325 thousand in am...

Lilly- backed weight-loss biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis make use of drug flunks period 2b, driving Indivior to reconsider $100M alternative

.Aelis Farma's chances of protecting a simple, beneficial choice on a $100 million alternative payme...

ProKidney halts stage 3 test not needed for cell treatment authorization

.ProKidney has actually stopped one of a set of period 3 trials for its tissue treatment for renal c...

Vaxcyte climbs on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what professionals called "remarkable" stage 1/2 records for its own 31-valent p...

Recursion's brain condition test shows insufficient proof of efficiency

.Recursion has discovered with an early exam of its own tech-enabled approach to medication discover...